FJX1 and cancer: While much remains unknown about the function of FJX1, emerging studies have identified FJX1 to be amplified or overexpressed in several types of cancers including breast [22, 23], lung [24], ovarian [19], colorectal [18], and head and neck cancers [25, 26], suggesting that it could be a genetic driver for cancer.